- Home
- ADPT vs CCB Comparison
ADPT vs CCB Comparison
Compare ADPT & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CCB
- Stock Information
- Founded
- ADPT 2009
- CCB 1997
- Country
- ADPT United States
- CCB United States
- Employees
- ADPT N/A
- CCB N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CCB Major Banks
- Sector
- ADPT Health Care
- CCB Finance
- Exchange
- ADPT Nasdaq
- CCB Nasdaq
- Market Cap
- ADPT 929.8M
- CCB 811.4M
- IPO Year
- ADPT 2019
- CCB 2018
- Fundamental
- Price
- ADPT $5.94
- CCB $79.54
- Analyst Decision
- ADPT Buy
- CCB Strong Buy
- Analyst Count
- ADPT 4
- CCB 2
- Target Price
- ADPT $6.75
- CCB $84.50
- AVG Volume (30 Days)
- ADPT 1.4M
- CCB 116.7K
- Earning Date
- ADPT 02-12-2025
- CCB 01-28-2025
- Dividend Yield
- ADPT N/A
- CCB N/A
- EPS Growth
- ADPT N/A
- CCB N/A
- EPS
- ADPT N/A
- CCB 2.98
- Revenue
- ADPT $177,282,000.00
- CCB $284,123,000.00
- Revenue This Year
- ADPT $6.48
- CCB N/A
- Revenue Next Year
- ADPT $18.84
- CCB $27.25
- P/E Ratio
- ADPT N/A
- CCB $28.31
- Revenue Growth
- ADPT N/A
- CCB 8.86
- 52 Week Low
- ADPT $2.28
- CCB $35.67
- 52 Week High
- ADPT $7.07
- CCB $86.27
- Technical
- Relative Strength Index (RSI)
- ADPT 61.49
- CCB 58.10
- Support Level
- ADPT $5.98
- CCB $73.80
- Resistance Level
- ADPT $6.93
- CCB $86.27
- Average True Range (ATR)
- ADPT 0.45
- CCB 2.80
- MACD
- ADPT 0.03
- CCB 0.09
- Stochastic Oscillator
- ADPT 75.53
- CCB 46.03
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CCB Coastal Financial Corporation
Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.